Recent Comments
- Bill on The Declaration of Pandemics
- Margaret McGregor on The Declaration of Pandemics
- admin on A Surgeon’s Story: Decision-making
- Margaret McGregor on A Surgeon’s Story: Decision-making
- LB on Has Bobby Kennedy’s campaign been infiltrated by intelligence operations?
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (18,061)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (16,207)
- New treatment paradigm for C. Diff colitis (14,861)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,817)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,283)
- How the FDA regulates compounding pharmacies (14,146)
- The Healthcare Channel hits 10 (13,686)
- The new CDC guidelines for prescribing opioid pain pills (9,167)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (8,697)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (8,401)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Z Medical centers
Laws governing genetic tests
December 19, 2013– Interviewed by Steven E. Greer, MD In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses
Posted in Columbia, Congress, FDA, Genetics
Leave a comment
CBS allows TV doctor to make egregious claims about statins
Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading
Posted in - Pharma, Cardiology, Cedars Sinai
Leave a comment
TAVI: Comparing CoreValve to Sapien
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
New therapies for hepatitis C
November 6, 2013- Interviewed by Steven E. Greer, MD In Part 1, Sammy Saab, MD, MPH, liver disease and GI doctor from UCLA, discusses the standard of care
A Bridge Too Far: Patient classifications for LVAD reimbursement
September 16, 2013- By Ashish Shah, MD, Cardiac transplant surgeon, The Johns Hopkins Medical Center Left ventricular assist devices (LVADs) arose from the ashes of the total artificial heart era.
Posted in - Opinion, Cardiac surgery, CMS, Johns Hopkins
Leave a comment
Super rapid acting insulin and inhaled insulin
September 9, 2013- Interviewed by Steven E. Greer, MD Jay Skyler, MD, PhD, Deputy Director of the Diabetes Research Institute at The University
Posted in - Biotech, - Pharma, Diabetes and endocrinology, Univ Miami
Leave a comment
Serelaxin to treat acute heart failure
July 8, 2013- The FDA granted Novartis the coveted “Breakthrough” status for drug serelaxin
Posted in Cardiology, UCLA
Leave a comment
The Yale led reanalysis of the BMP-2 InFuse trials
June 20, 2013- Interviewed by Steven E. Greer, MD Medtronic granted rare access to a team led my Yale’s Harlan Krumholz and turned over the complete
Posted in Orthopedic surgery, Yale
Leave a comment
Reasons for permanent slowdowns in healthcare spending growth
May 17, 2013- Interviewed by Steven E. Greer, MD Since 2010,
Posted in CMS, Harvard
Leave a comment
Bioabsorbable stents
May 14, 2013- William O’Neill, MD of Henry Ford discusses bioabsorbable coronary stents, and the U.S. Abbott trials.
Posted in Cardiac surgery, Cardiology, Henry Ford
Leave a comment
Renal denervation devices to treat hypertension
William O’Neill, MD of Henry Ford Hospital discusses renal denervation devices used to treat refractory hypertension. He is involved with the Medtronic device trials.
Posted in - Medical Devices, Cardiology, FDA, Henry Ford
Leave a comment
How Boston medical centers prepare for unconventional weapon attacks
May 3, 2013- Interviewed by Steven E. Greer, MD Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General
Posted in - Policy, Boston University, CDC, Congress, Emergency medicine, Harvard, Trauma Surgery
Leave a comment
How Boston medical centers prepare for unconventional weapon attacks
May 3, 2013- Interviewed by Steven E. Greer, MD
Questionable comments by Atul Gawande after the Boston Marathon bombings
April 20, 2013 By Steven E. Greer, MD Only two days after the April 15th Boston Marathon terrorist bombings, Harvard surgeon Atul
Posted in Harvard, Trauma Surgery
Leave a comment
TAVR Finances: William O’Neill, MD
Interviewed by Steven E. Greer, MD The clinical adoption of Transcatheter Aortic Valve Replacement (TAVR) has been slower than
Posted in Cardiac surgery, Cardiology, Henry Ford
Leave a comment
TAVR collaboration
April 12, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD, Director of the Structural Heart Disease Center at Henry Ford Hospital,
Posted in - Medical Devices, Henry Ford
Leave a comment
anti-PD1 and anti-PD-L1 drugs treating NSCLC
March 26, 2013 Interviewed By Steven E. Greer, MD
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment
The Damon Runyon Cancer Research Foundation panel
March 8, 2013 By Steven E. Greer, MD We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon
Posted in - Biotech, - Pharma, Harvard, Oncology
Leave a comment
The IOM report on counterfeit and substandard drugs
Prashant Yadav, PhD, Director, Health Care Research Initiative, University of Michigan, discusses
Posted in - Policy, Univ Michigan
Leave a comment
Double arm transplantation
Gerald Brandacher, MD, Scientific Director of the Composite Tissue Allotransplantation (Reconstructive Transplant) Program at Johns Hopkins discusses the first double arm transplant.
Posted in Johns Hopkins, Plastic surgery
Leave a comment